BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McAuley JR, Freeman TJ, Ekambaram P, Lucas PC, McAllister-Lucas LM. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis. Front Immunol. 2018;9:1887. [PMID: 30158935 DOI: 10.3389/fimmu.2018.01887] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Shi D, Zhang Z, Kong C. CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion. Technol Cancer Res Treat 2021;20:15330338211027915. [PMID: 34190011 DOI: 10.1177/15330338211027915] [Reference Citation Analysis]
2 Mellett M. Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease. Cellular Immunology 2020;354:104147. [DOI: 10.1016/j.cellimm.2020.104147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Liu X, Zhang X, Bi J, Li Z, Zhang Z, Kong C. Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells. J Cell Mol Med 2019;23:8128-38. [PMID: 31565867 DOI: 10.1111/jcmm.14683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Israël L, Glück A, Berger M, Coral M, Ceci M, Unterreiner A, Rubert J, Bardet M, Ginster S, Golding-Ochsenbein AM, Martin K, Hoyler T, Calzascia T, Wieczorek G, Hillenbrand R, Ferretti S, Ferrero E, Bornancin F. CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo. Oncogenesis 2021;10:32. [PMID: 33824280 DOI: 10.1038/s41389-021-00321-2] [Reference Citation Analysis]
5 Hou H, Li WX, Cui X, Zhou DC, Zhang B, Geng XP. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate. World J Gastroenterol 2019; 25(36): 5483-5493 [PMID: 31576094 DOI: 10.3748/wjg.v25.i36.5483] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bao W, Sun C, Sun X, He M, Yu H, Yan W, Wen F, Zhang L, Yang C. Targeting BCL10 by small peptides for the treatment of B cell lymphoma. Theranostics 2020;10:11622-36. [PMID: 33052237 DOI: 10.7150/thno.47533] [Reference Citation Analysis]
7 Peng L, He K, Cao Z, Bi L, Yu D, Wang Q, Wang J. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway. Mol Med Rep 2020;21:329-37. [PMID: 31939627 DOI: 10.3892/mmr.2019.10840] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Lu HY, Biggs CM, Blanchard-Rohner G, Fung SY, Sharma M, Turvey SE. Germline CBM-opathies: From immunodeficiency to atopy. J Allergy Clin Immunol 2019;143:1661-73. [PMID: 31060714 DOI: 10.1016/j.jaci.2019.03.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
9 Gowrikumar S, Primeaux M, Pravoverov K, Wu C, Szeglin BC, Sauvé CG, Thapa I, Bastola D, Chen XS, Smith JJ, Singh AB, Dhawan P. A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients. Cells 2021;10:2211. [PMID: 34571860 DOI: 10.3390/cells10092211] [Reference Citation Analysis]
10 McAuley JR, Bailey KM, Ekambaram P, Klei LR, Kang H, Hu D, Freeman TJ, Concel VJ, Hubel NE, Lee JL, Klei HB, Cheng J, Sekar P, Bridwell RE, Covic L, Lucas PC, McAllister-Lucas LM. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types. Oncogene 2019;38:7384-98. [PMID: 31420608 DOI: 10.1038/s41388-019-0958-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]